Achieve Life Sciences, Inc.
NASDAQ:ACHVBiotechnology
Healthcare
$6.78 -7.00%
-$0.38 today
- Market cap
- $697.68M
- Beta
- 2.26
- P/E (TTM)
- -5.1
- EPS (TTM)
- -$0.97
52W Low $2.00High $6.16
Volume 1.09M
Average 1.44M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$54.88M
FY 2025 · Annual
Net Income
-$54.65M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 229K | 228K |
| Gross Profit | 0 | 0 | 0 | (229K) | (228K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 23.97M | 30.08M | 15.81M | 22.82M | 22.96M |
| Selling, General & Admin | 9.13M | 10.72M | 11.44M | 16.25M | 31.87M |
| Operating Expenses | 33.09M | 40.8M | 27.25M | 38.84M | 54.65M |
| Depreciation & Amortization | 250K | 236K | 228K | 229K | 228K |
| EBITDA | (32.9M) | (40.33M) | (26.73M) | (37.42M) | (53.6M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (33.09M) | (40.8M) | (27.25M) | (39.07M) | (54.88M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 17K | 199K | 825K | 2.36M | 1.5M |
| Interest Expense | 0 | 1.79M | 2.85M | 2.18M | 819K |
| Other Income / Expenses | (58K) | (1.55M) | (2.57M) | (758K) | 232K |
| Income Before Tax | (33.15M) | (42.35M) | (29.82M) | (39.83M) | (54.65M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (33.15M) | (42.35M) | (29.82M) | (39.83M) | (54.65M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (4.05) | (3.95) | (1.50) | (1.24) | (1.25) |
| EPS (Diluted) | (4.05) | (3.95) | (1.50) | (1.24) | (1.25) |
| 8.12M | 10.59M | 19.83M | 32.07M | 43.59M | |
| 8.12M | 10.59M | 19.83M | 32.07M | 43.59M |
ACHV Earnings Waterfall · TTM
NASDAQ:ACHV · Revenue to Net Income
Key Ratios
EPS$-1.12
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-3.2
P/S Ratio0.0
Analysis
$0 of revenue converted into -$52.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.12, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
No competitor data available.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 3 | Initial statement of beneficial ownership | Oct 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 6, 2026 | |
| 8-K | Current report | Oct 1, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 21, 2026 | |
| SC 13G | SC 13G filing | Aug 17, 2026 |
How much revenue does ACHV generate?
Achieve Life Sciences, Inc. (ACHV) reported $0.00 of revenue in fiscal 2025.
Is ACHV profitable?
Achieve Life Sciences, Inc. (ACHV) reported -$54.65M of net income.
Continue the stock analysis
Jump to another research area for this company.